Literature DB >> 29665990

Severe asthma concomitant with allergic bronchopulmonary aspergillosis successfully treated with mepolizumab.

Naohiro Oda1, Nobuaki Miyahara2, Satoru Senoo1, Junko Itano3, Akihiko Taniguchi1, Daisuke Morichika1, Utako Fujii1, Yoshinobu Maeda1, Katsuyuki Kiura3, Arihiko Kanehiro4.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29665990     DOI： 10.1016/j.alit.2018.03.004

Source DB:  PubMed          Journal:  Allergol Int        ISSN： 1323-8930            Impact factor:   5.836


× No keyword cloud information.
  5 in total

1.  Allergic bronchopulmonary aspergillosis successfully treated with mepolizumab: Case report and review of the literature.

Authors:  Shuko Hirota; Yoichi Kobayashi; Takashi Ishiguro; Takashi Nishida; Naho Kagiyama; Yoshihiko Shimizu; Noboru Takayanagi
Journal:  Respir Med Case Rep       Date:  2018-11-24

2.  Successful treatment with mepolizumab in a case of allergic bronchopulmonary aspergillosis complicated with nontuberculous mycobacterial infection.

Authors:  Hironobu Tsubouchi; Shinpei Tsuchida; Shigehisa Yanagi; Takafumi Shigekusa; Mariko Miura; Kenjiro Sakaguchi; Nobuhiro Matsumoto; Masamitsu Nakazato
Journal:  Respir Med Case Rep       Date:  2019-06-05

Review 3.  Targeting eosinophils: severe asthma and beyond.

Authors:  Marco Caminati; Francesco Menzella; Lucia Guidolin; Gianenrico Senna
Journal:  Drugs Context       Date:  2019-07-23

Review 4.  Childhood allergic bronchopulmonary aspergillosis.

Authors:  Kana Ram Jat; Pankaj C Vaidya; Joseph L Mathew; Sunil Jondhale; Meenu Singh
Journal:  Lung India       Date:  2018 Nov-Dec

5.  Pulmonary Aspergilloma and Allergic Bronchopulmonary Aspergillosis Following the 2018 Heavy Rain Event in Western Japan.

Authors:  Eri Ando; Takamasa Nakasuka; Toshio Kubo; Akihiko Taniguchi; Kiichiro Ninomiya; Yuka Kato; Eiki Ichihara; Kadoaki Ohashi; Kammei Rai; Katsuyuki Hotta; Masaomi Yamane; Nobuaki Miyahara; Masahiro Tabata; Yoshinobu Maeda; Katsuyuki Kiura
Journal:  Intern Med       Date:  2021-08-06       Impact factor: 1.271
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.